We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

112 hedge funds and large institutions have $133M invested in Provention Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $4.5M | Put options by funds: $1.63M

8% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 37

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

3% less funds holding

Funds holding: 115 → 112 (-3)

7% less capital invested

Capital invested by funds: $143M → $133M (-$10M)

Holders
112
Holders Change
-3
Holders Change %
-2.61%
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
34
Reduced
37
Closed
22
Calls
$4.5M
Puts
$1.63M
Net Calls
+$2.87M
Net Calls Change
+$1.58M

Top Buyers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
+$10.8M
2
Verition Fund Management
Verition Fund Management
Connecticut
+$4.93M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$646K
4
DCM
DG Capital Management
New York
+$479K
5
Bank of America
Bank of America
North Carolina
+$398K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.51M
2
State Street
State Street
Massachusetts
-$1.35M
3
6CM
683 Capital Management
New York
-$1.27M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.03M
5
SG Americas Securities
SG Americas Securities
New York
-$945K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCA
101
Providence Capital Advisors
North Carolina
$2K – – –
S
102
SignatureFD
Georgia
$1K -$273 -43 -30%
BFC
103
Bedel Financial Consulting
Indiana
$1K – – –
Daiwa Securities Group
104
Daiwa Securities Group
Japan
$1K – – –
QCG
105
Quadrant Capital Group
Ohio
$1K – – –
TF
106
TimeScale Financial
Massachusetts
$1K – – –
EWM
107
Edge Wealth Management
New York
$1K +$318 +50 New
RFA
108
Reilly Financial Advisors
California
$1K +$1.27K +200 New
Manulife (Manufacturers Life Insurance)
109
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$180 -$8.27K -1,303 -4%
6CM
110
683 Capital Management
New York
– -$1.27M -198,429 Closed
Two Sigma Investments
111
Two Sigma Investments
New York
– -$599K -93,600 Closed
Barclays
112
Barclays
United Kingdom
– -$497K -77,683 Closed
State of Wisconsin Investment Board
113
State of Wisconsin Investment Board
Wisconsin
– -$429K -67,100 Closed
GTC
114
Ghost Tree Capital
New York
– -$320K -50,000 Closed
Vontobel Holding
115
Vontobel Holding
Switzerland
– -$192K -30,000 Closed
HighTower Advisors
116
HighTower Advisors
Illinois
– -$151K -23,616 Closed
HSBC Holdings
117
HSBC Holdings
United Kingdom
– -$150K -23,352 Closed
JF
118
Jump Financial
Illinois
– -$145K -22,600 Closed
Rafferty Asset Management
119
Rafferty Asset Management
New York
– -$137K -21,440 Closed
NC
120
NinePointTwo Capital
California
– -$134K -21,077 Closed
DekaBank Deutsche Girozentrale
121
DekaBank Deutsche Girozentrale
Germany
– -$126K -20,000 Closed
Franklin Resources
122
Franklin Resources
California
– -$98K -15,401 Closed
Principal Financial Group
123
Principal Financial Group
Iowa
– -$81K -12,587 Closed
I
124
INVST
Indiana
– -$76K -11,800 Closed
EGM
125
Engineers Gate Manager
New York
– -$73K -11,369 Closed
2 3 4
5
6

PRVB Hedge Fund Activity: Q4 2021 in Review

112 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q4 2021, worth a combined $133M — down 7% from $143M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of PRVB and 20 opened new positions — a net loss of 2 holders — while 37 trimmed existing stakes and 34 added.

The largest buyer was Sessa Capital, adding an estimated $10.8M. The largest seller was Millennium Management, cutting an estimated $1.51M.

  • 112 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q4 2021, down from 115 in Q3 2021.
  • Funds reported $133M of Provention Bio, Inc. Common Stock stock for Q4 2021, down 7% quarter-over-quarter.
  • 20 funds opened new Provention Bio, Inc. Common Stock positions in Q4 2021 and 22 closed out, a net change of -2 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q4 2021 was Sessa Capital, an estimated $10.8M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q4 2021 was Millennium Management, an estimated $1.51M sold.

Based on aggregated 13F filings for Q4 2021.